Top Biotech Sectors
Performance and market cap breakdown across 20 biotech sectors.
Combined Sector Value
$16.2T
(includes overlap)Active Sectors
20 sectors
Top Mover Today
+2.82%Drug Delivery & Formulation
| # | Sector | Market Cap | 1D % | 7D % | 30D % | Companies |
|---|---|---|---|---|---|---|
| 1 | 🧬 Biologics / Biosimilars1421 companies | $4.3T | +0.10% | -4.63% | -1.38% | 1421 |
| 2 | 💊 Small Molecule Drugs2108 companies | $4.2T | +0.32% | -4.18% | -9.42% | 2108 |
| 3 | 🧬 Digital Health & Biotech SaaS1551 companies | $1.5T | -0.39% | -2.66% | -14.45% | 1551 |
| 4 | 🔬 Cell & Gene Therapy772 companies | $1.2T | -0.50% | -2.67% | -2.67% | 772 |
| 5 | 🧪 RNA Therapeutics (non-mRNA)237 companies | $1.1T | -0.40% | -1.28% | +3.68% | 237 |
| 6 | 💉 Drug Delivery & Formulation1101 companies | $939.6B | +2.82% | +1.37% | +1.91% | 1101 |
| 7 | 🔍 Diagnostics & Precision Medicine2262 companies | $689.3B | -0.60% | -2.91% | -29.87% | 2262 |
| 8 | 🎯 Oncology (General)950 companies | $428.7B | +0.29% | +0.65% | -3.45% | 950 |
| 9 | 🤖 AI / Machine Learning600 companies | $423.3B | -0.48% | -1.86% | -36.71% | 600 |
| 10 | 🧬 Rare & Orphan Diseases239 companies | $299.7B | +1.32% | +2.86% | +1.43% | 239 |
| 11 | 🧬 mRNA Therapeutics33 companies | $291.9B | -1.19% | -2.48% | -0.77% | 33 |
| 12 | 🧬 Neuroscience & CNS657 companies | $225.1B | +0.21% | -1.18% | -6.00% | 657 |
| 13 | 🎯 Antibody-Drug Conjugates64 companies | $216.4B | +0.42% | -1.35% | -6.67% | 64 |
| 14 | ✂️ CRISPR / Gene Editing84 companies | $122.0B | +1.22% | +3.95% | +6.00% | 84 |
| 15 | 🧬 Proteomics & Protein Engineering229 companies | $105.0B | +0.49% | +1.44% | -9.50% | 229 |
| 16 | 🧬 Immunotherapy / Immuno-Oncology455 companies | $86.1B | +1.46% | +0.19% | -5.36% | 455 |
| 17 | 🧬 Regenerative Medicine454 companies | $55.8B | -0.35% | -6.63% | -32.94% | 454 |
| 18 | 🧬 Radiopharmaceuticals75 companies | $12.7B | +1.24% | +1.77% | +4.44% | 75 |
| 19 | ⚗️ Synthetic Biology118 companies | $9.1B | +1.29% | +7.06% | — | 118 |
| 20 | 🧬 Microbiome Therapeutics84 companies | $217.8M | -0.21% | -1.56% | -6.37% | 84 |